A citation-based method for searching scientific literature

Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy, Wendy C McKinnon, Nancie M Petrucelli, Robin L Bennett, Angela M Trepanier. J Genet Couns 2012
Times Cited: 185







List of co-cited articles
570 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Patient assessment of chatbots for the scalable delivery of genetic counseling.
Tara Schmidlen, Marci Schwartz, Kristy DiLoreto, H Lester Kirchner, Amy C Sturm. J Genet Couns 2019
31
12

Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
Andrea Farkas Patenaude, Michel Dorval, Lisa S DiGianni, Katherine A Schneider, Anu Chittenden, Judy E Garber. J Clin Oncol 2006
120
3

Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry?
Andrea F Patenaude, Nadine Tung, Paula D Ryan, Leif W Ellisen, Larissa Hewitt, Katherine A Schneider, Kenneth P Tercyak, Julie Aldridge, Judy E Garber. Psychooncology 2013
29
10



Guidelines for disclosing genetic information to family members: from development to use.
Béatrice Godard, Thierry Hurlimann, Martin Letendre, Nathalie Egalité. Fam Cancer 2006
55
5


Process studies in genetic counseling: peering into the black box.
B B Biesecker, K F Peters. Am J Med Genet 2001
104
3

Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.
D A Berry, G Parmigiani, J Sanchez, J Schildkraut, E Winer. J Natl Cancer Inst 1997
252
3

Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991
388
3

A new initiative on precision medicine.
Francis S Collins, Harold Varmus. N Engl J Med 2015
3


BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
489
3

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.
Douglas F Easton, Amie M Deffenbaugh, Dmitry Pruss, Cynthia Frye, Richard J Wenstrup, Kristina Allen-Brady, Sean V Tavtigian, Alvaro N A Monteiro, Edwin S Iversen, Fergus J Couch,[...]. Am J Hum Genet 2007
309
3

BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
D M Eccles, G Mitchell, A N A Monteiro, R Schmutzler, F J Couch, A B Spurdle, E B Gómez-García. Ann Oncol 2015
109
3

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
708
3

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.
Rebecca C Fitzgerald, Richard Hardwick, David Huntsman, Fatima Carneiro, Parry Guilford, Vanessa Blair, Daniel C Chung, Jeff Norton, Krishnadath Ragunath, J Han Van Krieken,[...]. J Med Genet 2010
334
3

Biallelic MUTYH mutations can mimic Lynch syndrome.
Monika Morak, Barbara Heidenreich, Gisela Keller, Heather Hampel, Andreas Laner, Albert de la Chapelle, Elke Holinski-Feder. Eur J Hum Genet 2014
60
5

Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline.
Scott M Weissman, Randall Burt, James Church, Steve Erdman, Heather Hampel, Spring Holter, Kory Jasperson, Matt F Kalady, Joy Larsen Haidle, Henry T Lynch,[...]. J Genet Couns 2012
84
3

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.
Tom Walsh, Ming K Lee, Silvia Casadei, Anne M Thornton, Sunday M Stray, Christopher Pennil, Alex S Nord, Jessica B Mandell, Elizabeth M Swisher, Mary-Claire King. Proc Natl Acad Sci U S A 2010
323
3




Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
3


Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
90
3



Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.
Lisa G Aspinwall, Jennifer M Taber, Wendy Kohlmann, Samantha L Leaf, Sancy A Leachman. Genet Med 2014
27
11

Measuring numeracy without a math test: development of the Subjective Numeracy Scale.
Angela Fagerlin, Brian J Zikmund-Fisher, Peter A Ubel, Aleksandra Jankovic, Holly A Derry, Dylan M Smith. Med Decis Making 2007
403
3

Communicating genetic and genomic information: health literacy and numeracy considerations.
D H Lea, K A Kaphingst, D Bowen, I Lipkus, D W Hadley. Public Health Genomics 2011
134
3

Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.
Ian K Komenaka, Jesse N Nodora, Lisa Madlensky, Lisa M Winton, Meredith A Heberer, Richard B Schwab, Jeffrey N Weitzel, Maria Elena Martinez. J Community Genet 2016
22
13

Teaching genomic counseling: preparing the genetic counseling workforce for the genomic era.
Gillian W Hooker, Kelly E Ormond, Kevin Sweet, Barbara B Biesecker. J Genet Couns 2014
42
7

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, Michael Berry, Saundra S Buys, Beth Crawford, Meagan Farmer, Susan Friedman, Judy E Garber, Seema Khan,[...]. J Natl Compr Canc Netw 2016
109
3

Low health literacy and health outcomes: an updated systematic review.
Nancy D Berkman, Stacey L Sheridan, Katrina E Donahue, David J Halpern, Karen Crotty. Ann Intern Med 2011
3

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
72
4

Closing the loop: physician communication with diabetic patients who have low health literacy.
Dean Schillinger, John Piette, Kevin Grumbach, Frances Wang, Clifford Wilson, Carolyn Daher, Krishelle Leong-Grotz, Cesar Castro, Andrew B Bindman. Arch Intern Med 2003
707
3


Disparities in BRCA testing: when insurance coverage is not a barrier.
Windy Olaya, Pamela Esquivel, Jan H Wong, John W Morgan, Adam Freeberg, Sharmila Roy-Chowdhury, Sharon S Lum. Am J Surg 2009
33
9

Validation of the Subjective Numeracy Scale: effects of low numeracy on comprehension of risk communications and utility elicitations.
Brian J Zikmund-Fisher, Dylan M Smith, Peter A Ubel, Angela Fagerlin. Med Decis Making 2007
186
3

Plain language: a strategic response to the health literacy challenge.
Sue Stableford, Wendy Mettger. J Public Health Policy 2007
86
3

Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).
Galen Joseph, Mary S Beattie, Robin Lee, Dejana Braithwaite, Carolina Wilcox, Maya Metrikin, Kate Lamvik, Judith Luce. J Genet Couns 2010
31
9

Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
415
3


Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.
Adam H Buchanan, Santanu K Datta, Celette Sugg Skinner, Gail P Hollowell, Henry F Beresford, Thomas Freeland, Benjamin Rogers, John Boling, P Kelly Marcom, Martha B Adams. J Genet Couns 2015
74
4

Genetics assessment at the end of life: suggestions for implementation in clinic and future research.
John Martin Quillin, Joann N Bodurtha, Thomas J Smith. J Palliat Med 2008
12
25

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
292
3


Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
Marc D Schwartz, Beth N Peshkin, Chanita Hughes, David Main, Claudine Isaacs, Caryn Lerman. J Clin Oncol 2002
175
3

Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Kyriaki Michailidou, Per Hall, Anna Gonzalez-Neira, Maya Ghoussaini, Joe Dennis, Roger L Milne, Marjanka K Schmidt, Jenny Chang-Claude, Stig E Bojesen, Manjeet K Bolla,[...]. Nat Genet 2013
742
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.